PHP
AGIO icon

Parkman Healthcare Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Parkman Healthcare Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8M Buy
669,046
+265,521
+66% +$8.05M 2.54% 9
2026
Q1 		$13.7M Buy
403,525
+303,921
+305% +$8.62M 1.41% 22
2025
Q4 		$2.71M Sell
99,604
-776
-0.8% -$27.2K 0.26% 82
2025
Q3 		$4.03M Buy
+100,380
New +$3.78M 0.42% 69
2024
Q4 		– Sell
-285,099
Closed -$12.7M – 90
2024
Q3 		$12.7M Sell
285,099
-161,317
-36% -$7.33M 1.62% 22
2024
Q2 		$19.2M Buy
+446,416
New +$16.1M 2.58% 7
2023
Q1 		– Sell
-50,000
Closed -$1.4M – 84
2022
Q4 		$1.4M Buy
+50,000
New +$1.41M 0.37% 64

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Parkman Healthcare Partners's AGIO Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Agios Pharmaceuticals (AGIO) stake by 66% in Q2 2026, buying an estimated $8.05M and bringing the position to 669,046 shares worth $24.8M. The position accounts for 2.54% of the portfolio, ranked #9.

Parkman Healthcare Partners first reported a position in AGIO in Q4 2022 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Parkman Healthcare Partners held 669,046 shares of Agios Pharmaceuticals worth $24.8M as of Q2 2026.
  • Parkman Healthcare Partners bought 265,521 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.05M.
  • Agios Pharmaceuticals made up 2.54% of Parkman Healthcare Partners's portfolio in Q2 2026, its #9 holding.
  • Parkman Healthcare Partners first reported a position in Agios Pharmaceuticals in Q4 2022 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.